XML 21 R22.htm IDEA: XBRL DOCUMENT
v3.20.1

Description of Business, Basis of Presentation and Significant Accounting Policies (Tables) | 3 Months Ended
--- | ---
Feb. 29, 2020
Accounting Policies [Abstract] |
Disaggregation of Revenue | The following table provides information about disaggregated revenue by products and services:
|  | Three months ended |
|  | February 29, 2020 |  |  | February 28, 2019 |
Processing and storage fees |  | $ | 7,406,288 |  |  | $ | 7,335,027 |
Public banking revenue |  |  | 154,079 |  |  |  | 134,365 |
Product revenue |  |  | 60,407 |  |  |  | 25,720 |
|  | $ | 7,620,774 |  |  | $ | 7,495,112 |
Schedule of Assets and Liabilities From Contracts With Customers | The following table provides information about assets and liabilities from contracts with customers:
|  | February 29, 2020 |  |  | November 30, 2019 |
Contract assets (sales commissions) |  | $ | 416,745 |  |  | $ | 398,535 |
Accounts receivables |  | $ | 5,766,684 |  |  | $ | 6,097,331 |
Short-term contract liabilities (deferred revenue) |  | $ | 8,610,304 |  |  | $ | 8,875,138 |
Long-term contract liabilities (deferred revenue) |  | $ | 24,454,967 |  |  | $ | 23,633,373 |
The Company, in general, requires the customer to pay for processing and storage services at the time of processing. Contract assets include deferred contract acquisition costs, which will be amortized along with the associated revenue. Contract liabilities include payments received in advance of performance under the contract and are realized with the associated revenue recognized under the contract. Accounts receivable consists of amounts due from clients that have enrolled and processed in the umbilical cord blood stem cell processing and storage programs related to renewals of annual plans and amounts due from license affiliates, and sublicensee territories. The Company did no t have asset impairment charges related to contract assets in the three months ended February 29, 2020 and February 28, 2019.
The following table presents changes in the Company’s contract assets and liabilities during the three months ended February 29, 2020:
|  | Balance at December 1, 2019 |  |  | Additions |  |  | Deductions |  |  | Balance at February 29, 2020 |
Contract assets (sales commissions) |  | $ | 398,535 |  |  | $ | 23,320 |  |  | ($ | 5,110 | ) |  | $ | 416,745 |
Accounts receivables |  | $ | 6,097,331 |  |  | $ | 8,438,904 |  |  | ($ | 8,769,551 | ) |  | $ | 5,766,684 |
Contract liabilities (deferred revenue) |  | $ | 32,508,511 |  |  | $ | 4,142,651 |  |  | ($ | 3,585,891 | ) |  | $ | 33,065,271 |
The following table presents changes in the Company’s contract assets and liabilities during the three months ended February 28, 2019:
|  | Balance at December 1, 2018 |  |  | Additions |  |  | Deductions |  |  | Balance at February 28, 2019 |
Contract assets (sales commissions) |  | $ | 329,231 |  |  | $ | 20,954 |  |  | ($ | 4,428 | ) |  | $ | 345,757 |
Accounts receivables |  | $ | 5,867,335 |  |  | $ | 9,017,603 |  |  | ($ | 9,190,776 | ) |  | $ | 5,694,162 |
Contract liabilities (deferred revenue) |  | $ | 28,682,515 |  |  | $ | 4,467,979 |  |  | ($ | 3,759,297 | ) |  | $ | 29,391,197 |
Financial Assets and Liabilities Measured at Fair Value on Recurring Basis | The following table summarizes the financial assets and liabilities measured at fair value on a recurring basis as of February 29, 2020 and November 30, 2019, respectively, segregated among the appropriate levels within the fair value hierarchy:
|  | Fair Value at February 29, 2020 |  |  | Fair Value Measurements at February 29, 2020 Using |
Description |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Marketable Securities |  | $ | 959,001 |  |  | $ | 959,001 |  |  |  | — |  |  |  | — |
|  | $ | 959,001 |  |  | $ | 959,001 |  |  |  | — |  |  |  | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration |  | $ | 3,443,645 |  |  | $ | — |  |  |  | — |  |  | $ | 3,443,645 |
Total |  | $ | 3,443,645 |  |  | $ | — |  |  |  | — |  |  | $ | 3,443,645 |
Contingent Consideration: |  |  |  |  |
Beginning Balance as of November 30, 2019 |  | $ | 3,495,057 |  |
Additions – Cord:Use earnout |  |  | — |  |
Fair value adjustment as of February 29, 2020 |  |  | (51,412 | ) |
Ending balance as of February 29, 2020 |  | $ | 3,443,645 |  |
|  | Fair Value at November 30, 2019 |  |  | Fair Value Measurements at November 30, 2019 Using |
Description |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Marketable securities |  | $ | 904,053 |  |  | $ | 904,053 |  |  |  | — |  |  |  | — |
|  | $ | 904,053 |  |  | $ | 904,053 |  |  |  | — |  |  |  | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration |  | $ | 3,495,057 |  |  | $ | — |  |  |  | — |  |  | $ | 3,495,057 |
Total |  | $ | 3,495,057 |  |  | $ | — |  |  |  | — |  |  | $ | 3,495,057 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of contract balances and changes in contract balances. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration